Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Neovacs buy JuKra95

Neovacs
Start price
€528,000
22.06.21 / 50%
Target price
€240,000,000
22.06.22
Performance (%)
-99.70%
End price
€1,588.0
23.06.22
Summary
This prediction ended on 23.06.22 with a price of €1,588.0. The BUY prediction by JuKra95 for Neovacs performed very badly with a performance of -99.70%. JuKra95 has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Neovacs - - - -
iShares Core DAX® 0.271% 2.504% 3.327% 50.436%
iShares Nasdaq 100 1.884% 3.490% 35.658% 88.226%
iShares Nikkei 225® 3.579% 8.127% 56.653% 65.166%
iShares S&P 500 0.151% 1.918% 24.108% 64.489%

Comments by JuKra95 for this prediction

In the thread Neovacs diskutieren
Prediction Buy
Perf. (%) -99.70%
Target price 3.000
Change
Ends at

Buy mit Kursziel 3,0

JuKra95 
0
Report Share
22.06.21
In the thread Trading Neovacs
Prediction Buy
Perf. (%) -99.70%
Target price 30000.000
Change
Ends at 22.06.22

Die von JuKra95 gewählte maximale Laufzeit wurde überschritten

JuKra95 
0
Report Share
23.06.22